Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vaxdyn

Vaxdyn?uq=iauh9QUh
2011 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE
$1.2M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of novel vaccines designed to offer prevention from infectious diseases. The company's vaccines uses antigens, immunomodulators, nanoparticles and mAbs, enabling doctors to decrease the impact on public health of infections caused by drug-resistant pathogens.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Campus Hospital Universitario Virgen del Rocio
  • Av. Manuel Siurot, s/n, Centro de Documentación Clínica
  • 41013 Seville
  • Spain

+34 606 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Vaxdyn’s full profile, request a free trial.

Vaxdyn Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Jan-2016 $1.2M 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Vaxdyn Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Caixa Capital Risc Corporate Venture Capital Minority 000 0000 000000 0
Ministry of Economy Other 000 0000 000000 0

Vaxdyn Executive Team (4)

Name Title Board
Seat
Contact
Info
Manuel Montoya Chief Operating Officer
Michael McConnell Ph.D Chief Scientific Officer
Pilar Pérez-Romero Ph.D Chairman & Chief Medical Officer
Juan Infante Ph.D Chief Executive Officer & Board Member

Vaxdyn Board Members (2)

Name Representing Role Since Contact
Info
Juan Infante Ph.D Self Chief Executive Officer & Board Member 000 0000
Pilar Pérez-Romero Ph.D Vaxdyn Chairman & Chief Medical Officer 000 0000